Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 6, Number 6—December 2000

Predominance of HIV-1 Subtype A and D Infections in Uganda

Dale J. Hu*Comments to Author , James Baggs†, Robert G. Downing*†, Danuta Pieniazek*, Jonathan Dorn*, Carol Fridlund*, Benon Biryahwaho‡, Sylvester D.K. Sempala‡, Mark A. Rayfield*, Timothy J. Dondero*, and Renu B. Lal*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †State of Washington, Department of Labor and Industries, Olympia, Washington; ‡Uganda Virus Research Institute/Centers for Disease Control and Prevention Research Collaboration, Uganda Virus Research Institute, Entebbe, Uganda

Main Article

Table 3

Clinical characteristics among a subset of persons infected with HIV-1 subtype A or Da

Characteristic Subtype A Subtype D p value
WHOa clinical stage n=37 n=46
1 or 2 8% 9% p=0.97
3 57% 54%
4 (AIDS) 35% 37%
CD4 n=29 n=26
Mean 253 187 p=0.24
Range 19-1,061 2-713
CD8 n=29 n=26
Mean 812 734 p=0.45
Range 288-2,000 139-1,458

aWHO = World Health Organization.

Main Article

Page created: December 17, 2010
Page updated: December 17, 2010
Page reviewed: December 17, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.